ANGO vs TWLO · rev $292.5M vs P/E 1087, rev $4.46B
AngioDynamics Inc (ANGO) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
ANGO currently screens at market cap $378.5M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the ANGO and TWLO stock pages for the full models.
Not investment advice.